The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Stamler David A since year 2005.
The trader's CIK number is 1440127.
At the time of this reporting, Stamler David A is the Chief Medical Officer of Auspex Pharmaceuticals, Inc. .
(stock ticker symbol ASPX).
See this page for all insider trading activities at Auspex Pharmaceuticals, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2015-03-16||ASPX||Auspex Pharmaceuticals, Inc.||Sale||3,000||79.81||239,436|
|2015-03-16||ASPX||Auspex Pharmaceuticals, Inc.||Option Ex||3,000||.90||2,700|
|2014-12-22||ASPX||Auspex Pharmaceuticals, Inc.||Sale||2,660||53.60||142,583|
|2014-12-22||ASPX||Auspex Pharmaceuticals, Inc.||Option Ex||2,660||.90||2,394|
|2010-08-02||XNPT||Xenoport Inc||Option Ex||2,500||.00||0|
|2010-01-28||XNPT||Xenoport Inc||Option Ex||1,000||.00||0|
|2009-08-10||XNPT||Xenoport Inc||Option Ex||2,500||.00||0|
|2009-01-14||XNPT||Xenoport Inc||Option Ex||3,309||.00||0|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Stamler David A (Chief Medical Officer of Auspex Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.